Novartis AG
SIX:NOVN
Novartis AG
Cash from Operating Activities
Novartis AG
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novartis AG
SIX:NOVN
|
Cash from Operating Activities
$14.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Operating Activities
-$13.9m
|
CAGR 3-Years
-318%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Roche Holding AG
SIX:ROG
|
Cash from Operating Activities
CHf16.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Operating Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novartis AG's Cash from Operating Activities?
Cash from Operating Activities
14.5B
USD
Based on the financial report for Dec 31, 2023, Novartis AG's Cash from Operating Activities amounts to 14.5B USD.
What is Novartis AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
1%
Over the last year, the Cash from Operating Activities growth was 2%. The average annual Cash from Operating Activities growth rates for Novartis AG have been 2% over the past three years , and 1% over the past ten years .